BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23896726)

  • 1. DLK1: a novel target for immunotherapeutic remodeling of the tumor blood vasculature.
    Chi Sabins N; Taylor JL; Fabian KP; Appleman LJ; Maranchie JK; Stolz DB; Storkus WJ
    Mol Ther; 2013 Oct; 21(10):1958-68. PubMed ID: 23896726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engagement of activated Notch signalling in collagen II-specific T helper type 1 (Th1)- and Th17-type expansion involving Notch3 and Delta-like1.
    Jiao Z; Wang W; Xu H; Wang S; Guo M; Chen Y; Gao J
    Clin Exp Immunol; 2011 Apr; 164(1):66-71. PubMed ID: 21235539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice.
    Fabian KP; Chi-Sabins N; Taylor JL; Fecek R; Weinstein A; Storkus WJ
    Oncoimmunology; 2017; 6(3):e1290035. PubMed ID: 28405524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice.
    Zhao X; Bose A; Komita H; Taylor JL; Chi N; Lowe DB; Okada H; Cao Y; Mukhopadhyay D; Cohen PA; Storkus WJ
    J Immunol; 2012 Feb; 188(4):1782-8. PubMed ID: 22246626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling.
    Huang CC; Cheng SH; Wu CH; Li WY; Wang JS; Kung ML; Chu TH; Huang ST; Feng CT; Huang SC; Tai MH
    Oncogene; 2019 Apr; 38(17):3201-3215. PubMed ID: 30626939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer.
    Wysocki PJ; Kazimierczak U; Suchorska W; Kotlarski M; Malicki J; Mackiewicz A
    Cancer Gene Ther; 2010 Jul; 17(7):465-75. PubMed ID: 20168352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.
    Kirner A; Mayer-Mokler A; Reinhardt C
    Hum Vaccin Immunother; 2014; 10(11):3179-89. PubMed ID: 25625928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathway.
    Boardman R; Pang V; Malhi N; Lynch AP; Leach L; Benest AV; Bates DO; Machado MJC
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1065-H1075. PubMed ID: 30681366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DLK1 promotes lung cancer cell invasion through upregulation of MMP9 expression depending on Notch signaling.
    Li L; Tan J; Zhang Y; Han N; Di X; Xiao T; Cheng S; Gao Y; Liu Y
    PLoS One; 2014; 9(3):e91509. PubMed ID: 24621612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8
    Dey S; Sutanto-Ward E; Kopp KL; DuHadaway J; Mondal A; Ghaban D; Lecoq I; Zocca MB; Merlo LMF; Mandik-Nayak L; Andersen MH; Pedersen AW; Muller AJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia.
    Al Haj Zen A; Oikawa A; Bazan-Peregrino M; Meloni M; Emanueli C; Madeddu P
    Circ Res; 2010 Jul; 107(2):283-93. PubMed ID: 20508179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
    Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
    Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLK1 regulates branching morphogenesis and parasympathetic innervation of salivary glands through inhibition of NOTCH signalling.
    García-Gallastegui P; Ibarretxe G; Garcia-Ramírez JJ; Baladrón V; Aurrekoetxea M; Nueda ML; Naranjo AI; Santaolalla F; Sánchez-del Rey A; Laborda J; Unda F
    Biol Cell; 2014 Aug; 106(8):237-53. PubMed ID: 24828459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
    Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
    J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft model.
    Tykodi SS; Satoh S; Deming JD; Chou J; Harrop R; Warren EH
    J Immunother; 2012 Sep; 35(7):523-33. PubMed ID: 22892449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine.
    Smalley Rumfield C; Pellom ST; Morillon Ii YM; Schlom J; Jochems C
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth.
    Huang Y; Lin L; Shanker A; Malhotra A; Yang L; Dikov MM; Carbone DP
    Cancer Res; 2011 Oct; 71(19):6122-31. PubMed ID: 21825014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment
    Park S; Oh JH; Park DJ; Zhang H; Noh M; Kim Y; Kim YS; Kim H; Kim YM; Ha SJ; Kwon YG
    Front Immunol; 2020; 11():620166. PubMed ID: 33584714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel population of local pericyte precursor cells in tumor stroma that require Notch signaling for differentiation.
    Patenaude A; Woerher S; Umlandt P; Wong F; Ibrahim R; Kyle A; Unger S; Fuller M; Parker J; Minchinton A; Eaves CJ; Karsan A
    Microvasc Res; 2015 Sep; 101():38-47. PubMed ID: 26092680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth.
    Segarra M; Williams CK; Sierra Mde L; Bernardo M; McCormick PJ; Maric D; Regino C; Choyke P; Tosato G
    Blood; 2008 Sep; 112(5):1904-11. PubMed ID: 18577711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.